The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
(2015) In JAMA Oncology 1(2). p.168-174- Abstract
- Multiple myeloma (MM) is consistently preceded by the precursor state, monoclonal gammopathy of undetermined significance (MGUS). The average annual risk of progression from MGUS to multiple myeloma is 0.5% to 1.0%. Current guidelines suggest life-long clinical follow-up of individuals diagnosed as having MGUS depending on risk stratification. The impact of diagnosing and conducting clinical follow-up of MGUS on MM survival is unclear.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7749352
- author
- Sigurdardottir, Elin Edda ; Turesson, Ingemar LU ; Lund, Sigrun Helga ; Lindqvist, Ebba K ; Mailankody, Sham ; Korde, Neha ; Björkholm, Magnus ; Landgren, Ola and Kristinsson, Sigurdur Y
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JAMA Oncology
- volume
- 1
- issue
- 2
- pages
- 168 - 174
- publisher
- American Medical Association
- external identifiers
-
- pmid:26181017
- scopus:84965091817
- pmid:26181017
- wos:000383668400008
- ISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2015.23
- language
- English
- LU publication?
- yes
- id
- fd1a312a-4650-4480-9e3a-649fe2248e00 (old id 7749352)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26181017?dopt=Abstract
- date added to LUP
- 2016-04-04 09:06:55
- date last changed
- 2024-10-27 21:17:14
@article{fd1a312a-4650-4480-9e3a-649fe2248e00, abstract = {{Multiple myeloma (MM) is consistently preceded by the precursor state, monoclonal gammopathy of undetermined significance (MGUS). The average annual risk of progression from MGUS to multiple myeloma is 0.5% to 1.0%. Current guidelines suggest life-long clinical follow-up of individuals diagnosed as having MGUS depending on risk stratification. The impact of diagnosing and conducting clinical follow-up of MGUS on MM survival is unclear.}}, author = {{Sigurdardottir, Elin Edda and Turesson, Ingemar and Lund, Sigrun Helga and Lindqvist, Ebba K and Mailankody, Sham and Korde, Neha and Björkholm, Magnus and Landgren, Ola and Kristinsson, Sigurdur Y}}, issn = {{2374-2445}}, language = {{eng}}, number = {{2}}, pages = {{168--174}}, publisher = {{American Medical Association}}, series = {{JAMA Oncology}}, title = {{The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.}}, url = {{http://dx.doi.org/10.1001/jamaoncol.2015.23}}, doi = {{10.1001/jamaoncol.2015.23}}, volume = {{1}}, year = {{2015}}, }